Tesamorelin (Copy)

/* ========================================================= ROYAL PEPTIDES — TESAMORELIN RESEARCH DOSSIER Premium Elementor HTML Widget Complete • Responsive • Fully Scoped ========================================================= */ #rp-tesa-premium, #rp-tesa-premium * { box-sizing: border-box; } #rp-tesa-premium { –rp-white: #f7fcff; –rp-text: #dceef5; –rp-soft: #a9cfda; –rp-teal: #67ebdc; –rp-lime: #b9f56d; –rp-gold: #f0dc45; width: 100%; max-width: 1120px; margin: 0 auto; padding: 8px 0 28px; color: var(–rp-white); font-family: inherit; } /* ========================================================= HERO ========================================================= */ #rp-tesa-premium .rp-hero { position: relative; overflow: hidden; margin: 0 0 18px; padding: 42px 40px; border: 1px solid rgba(102, 226, 236, .42); border-radius: 28px; background: radial-gradient( circle at 93% 4%, rgba(44, 224, 192, .28), transparent 34% ), radial-gradient( circle at 4% 0%, rgba(59, 141, 236, .31), transparent 40% ), linear-gradient( 145deg, rgba(25, 77, 160, .90), rgba(13, 128, 157, .77) ); box-shadow: 0 24px 58px rgba(4, 25, 71, .29), inset 0 1px 0 rgba(255,255,255,.14); } #rp-tesa-premium .rp-hero:after { content: “”; position: absolute; right: -100px; bottom: -150px; width: 320px; height: 320px; border-radius: 50%; background: radial-gradient( circle, rgba(185, 245, 109, .15), transparent 68% ); pointer-events: none; } /* ========================================================= HERO BADGE ========================================================= */ #rp-tesa-premium .rp-eyebrow { display: inline-flex; align-items: center; min-height: 34px; padding: 0 14px; margin-bottom: 18px; border: 1px solid rgba(185,245,109,.36); border-radius: 999px; background: rgba(131,226,130,.12); color: #dcffa8; font-size: 11px; font-weight: 900; line-height: 1; letter-spacing: .12em; text-transform: uppercase; } #rp-tesa-premium .rp-hero h2 { position: relative; z-index: 1; max-width: 820px; margin: 0 0 16px !important; color: #ffffff !important; font-size: clamp(34px,4vw,48px) !important; font-weight: 850 !important; line-height: 1.06 !important; letter-spacing: -.035em !important; } #rp-tesa-premium .rp-hero-lead { position: relative; z-index: 1; max-width: 860px; margin: 0 !important; color: #e6f5fa !important; font-size: 17px !important; font-weight: 500 !important; line-height: 1.72 !important; } /* ========================================================= PILLS ========================================================= */ #rp-tesa-premium .rp-pills { position: relative; z-index: 1; display: flex; flex-wrap: wrap; gap: 8px; margin-top: 24px; } #rp-tesa-premium .rp-pill { display: inline-flex; align-items: center; min-height: 37px; padding: 0 14px; border: 1px solid rgba(117,222,239,.31); border-radius: 999px; background: rgba(34,116,178,.44); color: #f2fbff; font-size: 12px; font-weight: 800; line-height: 1; } /* ========================================================= RESEARCH USE NOTICE ========================================================= */ #rp-tesa-premium .rp-notice { position: relative; z-index: 1; display: flex; align-items: center; gap: 14px; margin-top: 25px; padding: 16px 18px; border: 1px solid rgba(240,220,69,.43); border-radius: 17px; background: linear-gradient( 135deg, rgba(240,220,69,.16), rgba(28,107,154,.31) ); } #rp-tesa-premium .rp-notice-label { flex: 0 0 auto; display: inline-flex; align-items: center; justify-content: center; min-height: 31px; padding: 0 12px; border-radius: 999px; background: rgba(240,220,69,.15); color: #fff083; font-size: 10px; font-weight: 900; letter-spacing: .09em; text-transform: uppercase; } #rp-tesa-premium .rp-notice p { margin: 0 !important; color: #edf7fa !important; font-size: 13px !important; line-height: 1.55 !important; } /* ========================================================= MAIN SECTIONS ========================================================= */ #rp-tesa-premium .rp-section { margin: 14px 0; padding: 30px; border: 1px solid rgba(99,207,231,.31); border-radius: 22px; background: linear-gradient( 145deg, rgba(30,92,165,.73), rgba(20,129,154,.61) ); box-shadow: 0 14px 32px rgba(3,28,74,.17), inset 0 1px 0 rgba(255,255,255,.10); } #rp-tesa-premium .rp-section-head { display: flex; align-items: center; gap: 14px; margin-bottom: 18px; } #rp-tesa-premium .rp-number { display: flex; align-items: center; justify-content: center; width: 46px; height: 46px; flex: 0 0 46px; border: 1px solid rgba(102,234,214,.38); border-radius: 14px; background: linear-gradient( 145deg, rgba(47,185,218,.37), rgba(137,235,145,.18) ); color: #c5fff1; font-size: 12px; font-weight: 900; } #rp-tesa-premium .rp-kicker { display: block; margin-bottom: 5px; color: #84f1de; font-size: 10px; font-weight: 900; line-height: 1; letter-spacing: .14em; text-transform: uppercase; } #rp-tesa-premium .rp-section h3 { margin: 0 !important; color: #ffffff !important; font-size: 23px !important; font-weight: 850 !important; line-height: 1.2 !important; letter-spacing: -.02em !important; } #rp-tesa-premium .rp-section > p { max-width: 930px; margin: 10px 0 !important; color: #e0eef4 !important; font-size: 15px !important; line-height: 1.76 !important; } /* ========================================================= IDENTIFICATION GRID ========================================================= */ #rp-tesa-premium .rp-id-grid { display: grid; grid-template-columns: repeat(4,minmax(0,1fr)); gap: 11px; margin-top: 22px; } #rp-tesa-premium .rp-id-card { padding: 18px; border: 1px solid rgba(112,220,239,.29); border-radius: 16px; background: linear-gradient( 145deg, rgba(39,110,177,.73), rgba(23,145,159,.53) ); box-shadow: inset 0 1px 0 rgba(255,255,255,.08); } #rp-tesa-premium .rp-id-card span { display: block; margin-bottom: 7px; color: #8deedf; font-size: 10px; font-weight: 900; letter-spacing: .11em; text-transform: uppercase; } #rp-tesa-premium .rp-id-card strong { display: block; color: #ffffff; font-size: 14px; font-weight: 850; line-height: 1.35; } /* ========================================================= FEATURE GRID ========================================================= */ #rp-tesa-premium .rp-grid { display: grid; grid-template-columns: repeat(2,minmax(0,1fr)); gap: 12px; margin-top: 21px; } #rp-tesa-premium .rp-card { position: relative; padding: 21px 21px 21px 23px; border: 1px solid rgba(111,217,237,.28); border-radius: 17px; background: linear-gradient( 145deg, rgba(38,107,173,.71), rgba(22,143,157,.51) ); box-shadow: inset 0 1px 0 rgba(255,255,255,.07); } #rp-tesa-premium .rp-card:before { content: “”; position: absolute; top: 18px; bottom: 18px; left: 0; width: 3px; border-radius: 0 3px 3px 0; background: linear-gradient( 180deg, #59e4d3, #b9f56d ); } #rp-tesa-premium .rp-card h4 { margin: 0 0 8px !important; color: #ffffff !important; font-size: 16px !important; font-weight: 850 !important; line-height: 1.3 !important; } #rp-tesa-premium .rp-card p { margin: 0 !important; color: #dcebf2 !important; font-size: 14px !important; line-height: 1.68 !important; } /* ========================================================= FEATURED DOCUMENTATION PANEL ========================================================= */ #rp-tesa-premium .rp-featured { border-color: rgba(82,235,207,.39); background: radial-gradient( circle at 96% 5%, rgba(73,228,187,.21), transparent 33% ), linear-gradient( 145deg, rgba(28,102,172,.79), rgba(17,147,150,.65) ); } /* ========================================================= CHECKLIST ========================================================= */ #rp-tesa-premium .rp-checklist { display: grid; grid-template-columns: repeat(2,minmax(0,1fr)); gap: 10px; margin: 21px 0 0 !important; padding: 0 !important; list-style: none !important; } #rp-tesa-premium .rp-checklist li { position: relative; margin: 0 !important; padding: 13px 14px 13px 40px; border: 1px solid rgba(116,220,239,.24); border-radius: 13px; background: rgba(28,99,158,.47); color: #e7f3f8; font-size: 13.5px; font-weight: 600; line-height: 1.45; } #rp-tesa-premium .rp-checklist li:before { content: “✓”; position: absolute; left: 14px; top: 12px; color: #c0ff78; font-size: 14px; font-weight: 900; } /* ========================================================= TWO COLUMN CARDS ========================================================= */ #rp-tesa-premium .rp-two { display: grid; grid-template-columns: repeat(2,minmax(0,1fr)); gap: 12px; margin-top: 20px; } #rp-tesa-premium .rp-two-card { padding: 21px; border: 1px solid rgba(111,216,238,.27); border-radius: 17px; background: linear-gradient( 145deg, rgba(38,106,172,.69), rgba(22,141,158,.49) ); } #rp-tesa-premium .rp-two-card h4 { margin: 0 0 8px !important; color: #ffffff !important; font-size: 16px !important; font-weight: 850 !important; } #rp-tesa-premium .rp-two-card p { margin: 0 !important; color: #deedf3 !important; font-size: 14px !important; line-height: 1.7 !important; } /* ========================================================= CLARIFICATION CARD ========================================================= */ #rp-tesa-premium .rp-clarify { margin-top: 20px; padding: 20px; border: 1px solid rgba(102,226,236,.30); border-radius: 16px; background: linear-gradient( 135deg, rgba(31,102,170,.70), rgba(19,145,156,.51) ); } #rp-tesa-premium .rp-clarify strong { display: block; margin-bottom: 7px; color: #ffffff; font-size: 15px; font-weight: 850; } #rp-tesa-premium .rp-clarify p { margin: 0 !important; color: #deedf3 !important; font-size: 14px !important; line-height: 1.7 !important; } /* ========================================================= FAQ ========================================================= */ #rp-tesa-premium .rp-faq { display: grid; gap: 9px; margin-top: 20px; } #rp-tesa-premium .rp-faq details { overflow: hidden; border: 1px solid rgba(111,217,238,.27); border-radius: 15px; background: linear-gradient( 145deg, rgba(37,105,171,.70), rgba(22,141,157,.50) ); } #rp-tesa-premium .rp-faq summary { position: relative; padding: 17px 52px 17px 18px; color: #ffffff; font-size: 14.5px; font-weight: 800; line-height: 1.4; cursor: pointer; list-style: none; } #rp-tesa-premium .rp-faq summary::-webkit-details-marker { display: none; } #rp-tesa-premium .rp-faq summary:after { content: “+”; position: absolute; right: 18px; top: 50%; transform: translateY(-50%); color: #c0ff78; font-size: 22px; font-weight: 500; } #rp-tesa-premium .rp-faq details[open] summary:after { content: “−”; } #rp-tesa-premium .rp-faq details p { margin: 0 !important; padding: 0 18px 18px; color: #deedf3 !important; font-size: 14px !important; line-height: 1.72 !important; } /* ========================================================= FINAL RUO PANEL ========================================================= */ #rp-tesa-premium .rp-final { margin-top: 16px; padding: 31px; border: 1px solid rgba(240,220,69,.44); border-radius: 22px; background: radial-gradient( circle at 100% 0, rgba(240,220,69,.16), transparent 37% ), linear-gradient( 145deg, rgba(28,102,169,.79), rgba(18,137,153,.63) ); box-shadow: 0 15px 35px rgba(4,26,70,.18), inset 0 1px 0 rgba(255,255,255,.09); } #rp-tesa-premium .rp-final-label { display: inline-flex; align-items: center; min-height: 30px; padding: 0 12px; margin-bottom: 12px; border: 1px solid rgba(240,220,69,.36); border-radius: 999px; background: rgba(240,220,69,.10); color: #fff07c; font-size: 10px; font-weight: 900; letter-spacing: .12em; text-transform: uppercase; } #rp-tesa-premium .rp-final h3 { margin: 0 0 10px !important; color: #ffffff !important; font-size: 23px !important; font-weight: 850 !important; } #rp-tesa-premium .rp-final p { max-width: 920px; margin: 0 !important; color: #e4f0f5 !important; font-size: 14px !important; line-height: 1.72 !important; } /* ========================================================= MOBILE ========================================================= */ @media (max-width: 767px) { #rp-tesa-premium { padding: 3px 0 18px; } #rp-tesa-premium .rp-hero { padding: 27px 20px; border-radius: 21px; } #rp-tesa-premium .rp-hero h2 { font-size: 30px !important; } #rp-tesa-premium .rp-hero-lead { font-size: 15px !important; } #rp-tesa-premium .rp-notice { flex-direction: column; align-items: flex-start; gap: 8px; } #rp-tesa-premium .rp-section { padding: 23px 19px; border-radius: 19px; } #rp-tesa-premium .rp-section-head { align-items: flex-start; } #rp-tesa-premium .rp-section h3 { font-size: 20px !important; } #rp-tesa-premium .rp-section > p { font-size: 14px !important; } #rp-tesa-premium .rp-id-grid, #rp-tesa-premium .rp-grid, #rp-tesa-premium .rp-checklist, #rp-tesa-premium .rp-two { grid-template-columns: 1fr; } #rp-tesa-premium .rp-card p, #rp-tesa-premium .rp-two-card p, #rp-tesa-premium .rp-clarify p, #rp-tesa-premium .rp-faq details p { font-size: 13.5px !important; } #rp-tesa-premium .rp-final { padding: 24px 20px; border-radius: 19px; } #rp-tesa-premium .rp-final h3 { font-size: 20px !important; } #rp-tesa-premium .rp-final p { font-size: 13.5px !important; } } Research Material • Tesamorelin Tesamorelin Research Peptide Tesamorelin is a synthetic peptide research compound supplied by Royal Peptides exclusively for legitimate laboratory, analytical, and scientific research applications. Tesamorelin Research Peptide Laboratory Research Batch Traceability Analytical Documentation Research Use Only Not for human or veterinary use, administration, ingestion, injection, compounding, diagnostic, therapeutic, clinical, or personal use. 01 Compound Profile Tesamorelin Research Material Tesamorelin is a synthetic peptide compound described in scientific literature as an analogue of growth hormone-releasing hormone, also referred to as GHRH. This classification is presented solely for compound identification and scientific reference. It does not describe the intended use of the Royal Peptides research material. Royal Peptides supplies Tesamorelin strictly as a laboratory research material. Information on this page is not intended as clinical, therapeutic, diagnostic, preventive, veterinary, or personal-use guidance. 02 Identification Research Material Profile Clear identification and lot documentation are important when research materials are incorporated into controlled laboratory workflows. Compound Tesamorelin Classification Synthetic Peptide Material Type Research Peptide Intended Use Laboratory Research 03 Research Environment Controlled Laboratory Applications Royal Peptides Tesamorelin is supplied for professional research environments requiring appropriately identified peptide material for analytical, experimental, or reference-based laboratory work. Analytical Chemistry Suitable for appropriately designed laboratory workflows involving analytical evaluation and research-material characterization. Compound Identification Supports reference-based identification, material comparison, and organized laboratory evaluation. Chromatographic Analysis Research laboratories may independently evaluate materials using appropriate chromatographic methodologies. Spectrometric Analysis Appropriate analytical instrumentation may be used for independent compound identification and characterization. Stability Investigation Controlled protocols may evaluate research material under defined and documented laboratory conditions. Research Documentation Batch information and analytical records can support organized laboratory documentation and material traceability. 04 Quality Documentation Batch-Specific Analytical Information Researchers should evaluate documentation associated with the specific production lot incorporated into their laboratory work. General website information should not replace applicable batch-specific analytical records. Product and compound identification Batch or lot reference Analytical testing information Purity information where applicable Testing methodology where documented Certificate of Analysis information where available 05 Laboratory Traceability Lot Records & Research Documentation Maintaining accurate records helps laboratories associate analytical observations with the specific research lot incorporated into an experimental workflow. Lot Identification Record the compound name, applicable product identifier, production lot, and material receipt information. Analytical Records Preserve applicable analytical documentation, laboratory observations, storage records, and internal research references. 06 Laboratory Protocol Handling & Storage Professional Laboratory Handling Tesamorelin research material should be handled by individuals familiar with laboratory procedures, research-material identification, contamination control, and applicable laboratory safety practices. Laboratory Storage Researchers should follow storage information associated with the applicable product or batch documentation and maintain appropriate inventory and storage records. 07 Scientific Reference Compound Classification Scientific literature describes Tesamorelin as a synthetic analogue related to growth hormone-releasing hormone research. Scientific Context Only References to GHRH, growth hormone-releasing hormone, peptide classification, or independent scientific literature are provided solely to identify and describe the compound. They do not represent a recommendation for clinical, therapeutic, diagnostic, or personal use of the Royal Peptides research material. 08 Research Restrictions What This Material Is Not Intended For Royal Peptides Tesamorelin is not offered or represented as a medicine, supplement, food, cosmetic, prescription preparation, or consumer health product. Not for human administration Not for veterinary administration Not for ingestion Not for injection Not for personal experimentation Not for pharmaceutical compounding Not for pharmacy preparation Not for diagnostic or therapeutic use 09 Research FAQ Tesamorelin Research Questions What is Tesamorelin? Tesamorelin is a synthetic peptide compound described in scientific literature. Royal Peptides supplies this product exclusively as a laboratory research material. What type of peptide is Tesamorelin? Scientific literature describes Tesamorelin as a synthetic analogue related to growth hormone-releasing hormone. This information is presented solely for compound identification and scientific context. Is Royal Peptides Tesamorelin intended for human use? No. Royal Peptides Tesamorelin is supplied strictly for laboratory research and is not intended for human or veterinary use. Does Royal Peptides provide dosing instructions? No. Royal Peptides does not provide dosing, administration, injection, prescribing, treatment, or personal-use instructions for this research material. Can this material be used for compounding? This product is not offered or represented for pharmaceutical compounding, pharmacy preparation, clinical preparation, or administration. Is analytical documentation available? Batch-specific analytical documentation may be available depending on the applicable production lot. Researchers should review documentation associated with the specific material received. Why is the lot number important? Analytical documentation is associated with a specific production lot. Maintaining the applicable lot number supports traceability between research material, analytical documentation, and laboratory records. Research Use Only Laboratory Research Material For laboratory research use only. Not for human or veterinary use. Not intended for administration, ingestion, injection, personal experimentation, compounding, pharmacy preparation, diagnostic use, therapeutic use, clinical use, or the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition.